Lipoprotein lipase (LPL)1 is the major enzyme responsible for triglyceride hydrolysis of triglyceride-rich lipoproteins. This hydrolysis controls the rate-limiting step in the removal of triacylglycerol fatty acids from the circulation. Although LPL is synthesized by the parenchymal cells of many tissues, its site of function is at the luminal surface of the capillary endothelium (1). Heparan sulfate proteoglycans (HSPGs) may fulfill a crucial role in the translocation of LPL from sites of synthesis to functional sites and also may control the net amount of LPL that reaches the capillary endothelium.HSPGs participate in LPL metabolism at several levels. In recent years, three additional proteins have been implicated in the cell surface binding of LPL. These proteins are the low density lipoprotein receptor-related protein (LRP) (17, 18), gp330, also known as megalin (19), and the amino-terminal fragment of apolipoprotein B (20, 21). Both LRP and gp330 are transmembrane proteins that belong to the LDL receptor gene family and have been shown to bind LPL with high affinity in vitro (18,22). The apolipoprotein B fragment is a secreted protein that binds directly to HSPGs and has been proposed to mediate the binding of LPL to HSPGs.Many questions about the role of HSPGs in LPL metabolism remain to be answered. Do HSPGs function in other aspects of LPL metabolism? For example, are HSPGs necessary for the secretion of newly synthesized LPL? Are HSPGs solely responsible for LPL binding to cell surfaces or do other proteins participate? Are HSPGs or other LPL-binding proteins responsible for the intracellular degradation of LPL? Does HSPG binding influence the enzymatic activity of LPL? In most systems, it is difficult to definitively assign all of these functions to HSPGs, since most experimental systems also contain LRP, gp330, or apolipoprotein B.In this report, we have used proteoglycan-deficient and CHO-K1 cells as a model system to investigate the significance of the LPL-HSPG interaction. CHO-K1 cells are a good model system since they are known to produce endogenous LPL (23). In addition, CHO-K1 cells have two types of proteoglycans: heparan sulfate (70%) and chondroitin sulfate (30%) (24); thus, the major proteoglycan in these cells is the proteoglycan responsible for binding LPL. Two CHO cell mutants, pgsA 745 and pgsB 761, lack both chondroitin sulfate and HSPGs (24,25). We compared cell surface binding, degradation, distribution, and enzymatic efficiency of LPL in these proteoglycan-